Cleared Traditional

K950148 - CHEMMATE(TM) CD43

K950148 is an FDA 510(k) clearance for CHEMMATE(TM) CD43, manufactured by Biotek Solutions, Inc.. The device is a Class 2 Immunology device with product code DEH cleared through the Traditional 510(k) pathway after a 532-day FDA review.

K950148 · Biotek Solutions, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1996
Decision
532d
Days
Class 2
Risk

K950148 is an FDA 510(k) clearance for the CHEMMATE(TM) CD43. Classified as Lambda, Antigen, Antiserum, Control (product code DEH), Class II - Special Controls.

Submitted by Biotek Solutions, Inc. (Santa Barbara, US). The FDA issued a Cleared decision on July 2, 1996 after a review of 532 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5550 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Immunology submissions.

View all Biotek Solutions, Inc. devices

FDA 510(k) Submission Details - K950148

510(k) Number K950148 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 1995
Decision Date July 02, 1996
Days to Decision 532 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
427d slower than avg
Panel avg: 105d · This submission: 532d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DEH Device Classification - Class 2, Special Controls

Product Code DEH Lambda, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DEH Lambda, Antigen, Antiserum, Control

All 45
Devices cleared under the same product code (DEH) and FDA review panel - the closest regulatory comparables to K950148.
VENTANNA ANTI-DESMIN PRIMARY ANTIBODY
K941516 · Ventana Medical Systems, Inc. · Feb 1997
VENTANA ANTI-CD5 PRIMARY ANTIBODY
K941782 · Ventana Medical Systems, Inc. · Sep 1996
DAKO LABELED STREPTAVIDIN-BIOTIN 2 KIT, AND ENVISION
K951965 · Dako Corp. · Jul 1996
VENTANNA ANTI-CD3 PRIMARY ANTIBODY
K941505 · Ventana Medical Systems, Inc. · May 1996
KERATIN PRIMARY ANTIBODY
K935161 · Ventana Medical Systems, Inc. · Mar 1996
ANTI-KERATIN-HMW PRIMARY ANTI-BODY
K941173 · Ventana Medical Systems, Inc. · Mar 1996